Natural health product · NPN 80091245
Tamaflex
No: licence discontinued
The licence holder discontinued the product licence.
Licence status Discontinued; licensed March 14, 2019.
- Natural Product Number (NPN)
- 80091245
- Licence holder
- GNC Canada Holdings ULC
- Dosage form
- Capsule
- Route
- Oral
- Licensing route
- Non-Traditional
- First licensed
- March 14, 2019
Medicinal ingredients
Per dosage unit, as licensed.
| Ingredient | Amount | Source and potency |
|---|---|---|
| Boswellia serrata | 50 mg | New material |
| Curcuma longa | 37.5 mg | Rhizome; 15 % Curcuminoids; 7:1 extract; equivalent to 262.5 mg dried herb |
| Tamarindus indica | 75 mg | Seed(s); 90 % Proanthocyanidins; 8:1 extract; equivalent to 600 mg dried herb |
What it is licensed for
The licence’s own wording. Directions, doses, cautions and warnings are on the official record and the label.
- Helps to improve joint health by reducing knee joint pain, knee joint stiffness and improving physical function associated with daily physical activity. Helps to reduce/relieve knee joint pain associated with daily physical activity. Helps to reduce knee stiffness associated with daily physical activity. Helps to promote joint comfort associated with daily physical activities. Helps to promote joint movement and physical functioning associated with daily physical activity by reducing joint pain and stiffness. Helps to improve ability to perform daily activities by reducing joint stiffness. Helps relieve joint pain associated with daily physical activity in 14 days.
Non-medicinal ingredients
Calcium silicate; Dicalcium phosphate; Silicon dioxide; Microcrystalline cellulose; Hypromellose; Magnesium stearate